Independent variety trials help farmers separate meaningful genetic improvements from marketing claims. As seed regulations evolve, who will pay to keep that information available?
Imagine you’re running an independent seed company. You’ve spent years investing in a promising new variety. You want farmers to know how good it is. So you help fund an independent trial to demonstrate its performance.
The results come back. Your variety looks good. Unfortunately, your competitor’s variety looks even better. Congratulations. You’ve just helped sell somebody else’s seed.
I’ve been thinking about this scenario because it exposes an economic problem hiding inside two seemingly unrelated stories we published this week.
In the latest episode of On the Brink, SeCan’s Jeff Reid argues that Canada’s independent seed companies can become a much bigger force in plant breeding by pooling their financial resources. SeCan’s members already have approximately $1.7 billion invested in the infrastructure that delivers varieties to farmers.
Reid believes collective investment could help smaller companies compete without having to match the enormous budgets of multinational firms.
Meanwhile, Manitoba Seed Growers’ Association Executive Director Jennifer Seward is raising questions about what happens to independent variety performance information if crops such as peas, lentils and flax move to a less restrictive registration system.
That could eliminate mandatory preregistration merit testing for those crops. It wouldn’t eliminate the need for reliable performance data.
And therein lies the paradox.
The seed industry is exploring how competitors can collectively finance the creation of better varieties while potentially making it harder to finance the independent evidence that tells farmers which varieties actually are better.
Economists have a name for the underlying problem: the free-rider problem. Independent variety testing produces information that benefits farmers, seed companies and the broader industry. But its value isn’t necessarily captured by whoever pays for it. A company can benefit from a trusted testing system without contributing proportionately to its costs.
That’s manageable when testing requirements establish a common obligation. It becomes more complicated when participation is voluntary.
Seward makes this concern particularly tangible. Manitoba’s variety evaluation program already operates close to cost recovery. Its trials evaluate registered varieties, and changes to preregistration requirements raise important questions about where the funding and responsibility for performance assessment will sit.
Now consider Reid’s proposal from the opposite direction. His argument is that independent companies can accomplish collectively what they cannot afford individually. That’s not just a strategy for plant breeding. It may be precisely the economic principle needed to preserve the credibility of the variety marketplace.
The distinction is that companies should compete fiercely over genetics while recognizing that some of the information needed to evaluate those genetics is more valuable when everyone trusts it.
Think of it as competing on the same playing field while sharing the cost of making sure the scoreboard works. That doesn’t mean retaining every regulatory requirement. Faster registration may be exactly what some crops need, particularly when farmers are looking for new disease resistance or other urgently needed improvements.
Nor does it mean every company should be compelled to fund every trial. It means we need to think carefully about the incentives we’re creating.
If independent data becomes harder to finance, the companies with the deepest pockets may have an advantage in generating and promoting their own performance evidence. Smaller breeders could find themselves competing not just on the quality of their genetics, but on their ability to demonstrate that quality.
That would be a peculiar outcome for reforms intended to encourage innovation and competition.
There’s an opportunity here that goes beyond protecting existing institutions. What if Canada’s independent seed companies approached trusted regional performance data with the same collective-investment philosophy Reid is proposing for breeding? What if we recognized that a credible comparison system isn’t merely a regulatory expense, but shared competitive infrastructure?
We already understand why it makes sense to pool resources to create something no individual company could easily produce alone. Maybe the next step is recognizing that proving its value can require the same approach.
Because the real danger isn’t that Canada will produce too many new varieties. It’s that we’ll create a more competitive seed marketplace while quietly undermining one of the things that makes competition meaningful: the farmer’s ability to tell who’s actually winning.
